L364-0084 Screening compound: N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

L364-0084 Screening compound: N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide
L364-0084 Screening compound: N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L364-0084
N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L364-0084

Molecular Formula

C24H21N5O5S (C24 H21 N5 O5 S)

Compound Name

N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

IUPAC name

N-methyl-4-[1-methyl-5-(3-methyl-2-oxo-23-dihydro-13-benzoxazole-6-sulfonamido)-1H-13-benzodiazol-2-yl]benzamide

SMILES

CNC(c(cc1)ccc1-c1nc(cc(cc2)NS(c(cc3)cc(O4)c3N(C)C4=O)(=O)=O)c2n1C)=O

InChI

InChI=1S/C24H21N5O5S/c1-25-23(30)15-6-4-14(5-7-15)22-26-18-12-16(8-10-19(18)28(22)2)27-35(32,33)17-9-11-20-21(13-17)34-24(31)29(20)3/h4-13,27H,1-3H3,(H,25,30)

InChI Key

CCPDMPDVQJDLIX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247831

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

491.53

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.762

Distribution Coefficient, logD

2.757

Water Solubility, LogSw

-3.62

Polar Surface Area

99.328

Acid Dissociation Constant (pKa)

9.87

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

L364-0084 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L364-0084 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L364-0084?
Check Price and Availability of L364-0084, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L364-0084 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L364-0084
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L364-0084
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L364-0084 available by request